Atria Wealth Solutions’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$857K Sell
12,419
-24,067
-66% -$1.64M 0.02% 704
2025
Q1
$2.57M Sell
36,486
-5,851
-14% -$483K 0.03% 547
2024
Q4
$3.64M Buy
42,337
+2,315
+6% +$250K 0.04% 443
2024
Q3
$4.77M Sell
40,022
-5,109
-11% -$681K 0.05% 365
2024
Q2
$6.44M Buy
45,131
+5,463
+14% +$724K 0.07% 282
2024
Q1
$5.11M Buy
39,668
+2,619
+7% +$312K 0.06% 334
2023
Q4
$3.83M Buy
37,049
+8,266
+29% +$817K 0.05% 379
2023
Q3
$2.62M Buy
28,783
+5,275
+22% +$465K 0.04% 477
2023
Q2
$1.9M Buy
23,508
+5,542
+31% +$453K 0.03% 582
2023
Q1
$1.44M Sell
17,966
-2,458
-12% -$174K 0.02% 666
2022
Q4
$1.38M Buy
20,424
+7,836
+62% +$459K 0.02% 633
2022
Q3
$627K Buy
12,588
+8,488
+207% +$455K 0.01% 911
2022
Q2
$228K Sell
4,100
-1,976
-33% -$110K ﹤0.01% 1370
2022
Q1
$340K Buy
+6,076
New +$312K 0.01% 1257

Other funds holding NVO